Codes / ICD10CM / F18.2

F18.2 Inhalant dependence

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Inhalant Dependence
  • Medical Term: Inhalant Dependence

Summary

Inhalant dependence is a substance use disorder characterized by a problematic pattern of inhalant use leading to clinically significant impairment or distress. It involves a combination of physiological, behavioral, and cognitive symptoms related to continued use despite adverse consequences. This condition may include tolerance, withdrawal, and compulsive use, impacting physical health, mental functioning, and daily life.

Causes

Inhalant dependence develops from repeated misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects. Inhalants are often common household or industrial products, such as glue, paint thinners, aerosols, or solvents. Prolonged use can alter brain chemistry, leading to dependence and related health issues.

Risk Factors

  • Adolescents and young adults are more likely to experiment with inhalants.
  • Individuals with a history of substance abuse or mental health disorders.
  • Accessibility to inhalant products.
  • Lack of proper supervision or guidance.

Symptoms

  • Intense cravings or compulsive inhalant use.
  • Coordination problems, dizziness, or lethargy.
  • Unexplained behavioral changes such as aggression or mood swings.
  • Cognitive impairment or memory issues.
  • Withdrawal symptoms when use is reduced or stopped.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other conditions, but diagnosis relies primarily on clinical criteria.

Treatment Options

Treatment may involve behavioral therapies, such as cognitive-behavioral therapy, to address dependence and support recovery. In some cases, medications may be used to manage withdrawal symptoms or co-occurring conditions. Supportive care and long-term follow-up are often necessary.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, co-occurring conditions, and access to treatment. Long-term follow-up is important to monitor for relapse and address ongoing health needs. Early intervention improves outcomes.

Complications

  • Organ damage, particularly to the liver, kidneys, or brain.
  • Respiratory issues, including lung damage.
  • Neurological problems, such as cognitive decline or seizures.
  • Increased risk of accidents or injuries due to impaired coordination.

Lifestyle & Prevention

  • Avoiding inhalant use and educating others about its risks.
  • Seeking healthy coping mechanisms for stress or peer pressure.
  • Maintaining open communication with healthcare providers about substance use concerns.
  • Engaging in regular physical activity and supportive social networks.

When to Seek Professional Help

Seek help if inhalant use is causing problems at work, school, or in relationships, or if withdrawal symptoms occur when stopping use. Persistent cravings, loss of control over use, or continued use despite negative consequences also warrant professional evaluation.

Tips for Medical Coders

Document the presence of tolerance, withdrawal, or compulsive use patterns to support the diagnosis. Include details about the impact of inhalant use on daily functioning and any co-occurring conditions. Ensure documentation aligns with clinical criteria for dependence.

Book a walkthrough

F18.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.